Empagliflozin improves kidney outcomes in patients with heart failure and CKD

被引：0
|
作者：
Ellen F. Carney
机构：
[1] Nature Reviews Nephrology,
来源：
Nature Reviews Nephrology | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：14 / 14
相关论文
共 50 条
  • [31] Iron Supplementation Improves Cardiovascular Outcomes in Patients with Heart Failure
    Zhou, Xiang
    Xu, Weiting
    Xu, Youjia
    Qian, Zhiyuan
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (08): : 955 - 963
  • [32] Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
    Mone, Pasquale
    Lombardi, Angela
    Kansakar, Urna
    Varzideh, Fahimeh
    Jankauskas, Stanislovas S.
    Pansini, Antonella
    Marzocco, Stefania
    De Gennaro, Stefano
    Famiglietti, Michele
    Macina, Gaetano
    Frullone, Salvatore
    Santulli, Gaetano
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (01): : 116 - 122
  • [33] Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure
    Rascher, Juliane
    Cotton, Dan
    Haertter, Sebastian
    Brueckmann, Martina
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (09) : 2215 - 2222
  • [34] Chronic kidney disease (CKD) and CKD-ism in heart failure - what a mess!
    Pellicori, Pierpaolo
    Kalra, Paul R.
    Clark, Andrew L.
    Friday, Jocelyn M.
    Cleland, John G. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11) : 2196 - 2198
  • [35] External counterpulsation improves cardiac outcomes in patients with chronic heart failure
    Viayaraghavan, K
    Santora, L
    Kahn, J
    Abbott, N
    Torelli, J
    Vardi, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 192A - 192A
  • [36] Discharge education improves clinical outcomes in patients with chronic heart failure
    Koelling, TM
    Johnson, ML
    Cody, RJ
    Aaronson, KD
    CIRCULATION, 2005, 111 (02) : 179 - 185
  • [37] Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline
    Januzzi, James
    Ferreira, Joao Pedro
    Boehm, Michael
    Kaul, Sanjay
    Wanner, Christoph
    Brueckmann, Martina
    Petrie, Mark C.
    Ofstad, Anne Pernille
    Zeller, Cordula
    George, Jyothis
    Fitchett, David
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 386 - 388
  • [38] Empagliflozin Improves Heart Failure Caused by Pressure Overload by Regulating Cardiac Metabolism
    Li, Xuan
    Liu, Jia
    Ren, Di
    Zhang, Jingwen
    Han, Ying
    Li, Ji
    CIRCULATION, 2019, 140
  • [39] Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
    Boehm, Michael
    Anker, Stefan
    Mahfoud, Felix
    Lauder, Lucas
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Brueckmann, Martina
    Saloustros, Ilias
    Schueler, Elke
    Wanner, Christoph
    Zannad, Faiez
    Packer, Milton
    Butler, Javed
    EUROPEAN HEART JOURNAL, 2023, 44 (05) : 396 - 407
  • [40] Empagliflozin in the treatment of heart failure
    Shafiq, Aimen
    Hameed, Ishaque
    Biegus, Jan
    Fudim, Marat
    Khan, Muhammad Shahzeb
    FUTURE CARDIOLOGY, 2024, 20 (5-6) : 251 - 261
12345